Fabiana Napolitano

11PUBLICATIONS
43CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 24, 2025
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.

Chang-Ching A Lin, María Rosario Chica-Parrado, Nisha Unni

|Sep 03, 2024
Mapping cellular interactions from spatially resolved transcriptomics data.

James Zhu, Yunguan Wang, Woo Yong Chang

|Mar 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.

Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang

|Dec 09, 2023
Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors.

Fabrizio Di Costanzo, Fabiana Napolitano, Fabio Salomone

|Aug 11, 2023
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer.

Stefania Belli, Ada Pesapane, Alberto Servetto

Pageof 2